Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Google Podcasts | Spotify | Stitcher | Email | TuneIn | RSS
In this episode Morris Miller returns to explain how the COVID-19 pandemic has changed his business and made the demand for the disinfection robots his company makes to skyrocket. Last time Morris was on the show was 9 months ago and a lot has changed since then. Numerous peer reviewed studies have come out about saying with certainty that the Lightstrike Pulsed Xenon Disinfection robot does in fact kill SARS-CoV-2. Morris discusses how the technology is being adapted by an increasing number of organizations, all with fantastic results. He also looks into what the future may hold when it comes to fighting the pandemic from a disinfection standpoint.
Morris Miller, CEO of XENEX. Xenex is a world leader in automated room disinfection. Through the use of Xenon technology and innovative hospital disinfection protocols, the company has helped hospitals achieve significant infection reduction results.
As CEO, Morris is responsible for the company’s overall business strategy and oversight of day-to-day operations.
Originally from San Antonio, TX, Morris is a graduate of the Dedman School of Law at Southern Methodist University, The University of Texas at Austin, and Phillips Exeter Academy. He is the founder of Sequel and Cutstone Ventures, which invests in/acts as an advisor to numerous start-ups such as Inventables, Adometry, and Golfballs.com. He started Curtis Hill Publishing, the first company to publish Texas case law on CD-ROM, and he was also the co-founder and President/CEO of Rackspace (NYSE: RAX). Morris is a member of APIC, BioMed SA, and ACG Central Texas.